Hedge Fund Database

RA CAPITAL MANAGEMENT, LP

Adviser information for RA CAPITAL MANAGEMENT, LP last updated from Form ADV on March 29th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 130
Investment Advisory/Research 80
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 11 $11.3B
Non-Discretionary 0 $0
Total 11 $11.3B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 10 $11.2B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses <5 $95.8M
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 45

Services

Advisory Services Portfolio management for pooled investment vehiclesPortfolio management for businesses or institutional clients
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-73980
SEC ERA File Number 801-73980
SEC CIK Numbers 1346824
SEC CRD Numbers 160174
Legal Entity Identifier 549300ZV6X2KFAD7UG21

Principal Office

200 BERKELEY STREET
18TH FLOOR
BOSTON
MA
United States
Monday - Friday, 9:00AM - 5:00PM
Tel: 617-778-2500, Fax: 617-778-2510

Websites

www.racap.com www.linkedin.com/company/ra-capital-management-llc/ www.rapport.bio twitter.com/rapport_bio www.linkedin.com/company/rapport-bio/ www.peterkolchinsky.com/

Chief Compliance Officer

ERIC ROSE
200 BERKELEY STREET
18TH FLOOR
BOSTON
MA
United States
Tel: 617-875-0328
Fax: 617-778-2510
(Full email address available in API data)

Regulatory Contact

BRETT SCHELLER
COMPLIANCE OFFICER
200 BERKELEY STREET
18TH FLOOR
BOSTON
MA
United States
Tel: 412-491-9532
Fax: 617-778-2510
(Full email address available in API data)

Industry Affiliates

RA CAPITAL HEALTHCARE FUND GP, LLC Sponsor, GP, manager of pooled investment vehicles
RA CAPITAL NEXUS FUND GP, LLC Sponsor, GP, manager of pooled investment vehicles
RA CAPITAL NEXUS FUND II GP, LLC Sponsor, GP, manager of pooled investment vehicles
RA CAPITAL NEXUS FUND III GP, LLC Sponsor, GP, manager of pooled investment vehicles
RA CAPITAL PLANETARY HEALTH FUND GP, LLC Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
RA CAPITAL HEALTHCARE FUND, LP Hedge Fund $9,377.2M $2.0M 1046
RA CAPITAL NEXUS FUND, L.P. Venture Capital Fund $309.3M $10.0M 95
RA CAPITAL NEXUS II FUND, L.P. Venture Capital Fund $429.8M $10.0M 196
RA CAPITAL NEXUS III FUND, L.P. Venture Capital Fund $1,048.7M $10.0M 234
RA CAPITAL PLANETARY HEALTH FUND, LP Venture Capital Fund $62.2M $0.0M 17

Control Persons

Name Type Entity Title Since Ownership
KOLCHINSKY, PETER, (NMN) Individual – PORTFOLIO MANAGER 10/2019 < 5%
ALDRICH, RICHARD, H. (MI ONLY) Individual – PARTNER 10/2019 10-25%
SHAH, RAJEEV, MAHESH Individual – PORTFOLIO MANAGER 10/2019 < 5%
CALIRI, CHRISTOPHER, JAMES Individual – CHIEF INFORMATION OFFICER 12/2018 < 5%
ROSE, ERIC, PAUL Individual – CHIEF COMPLIANCE OFFICER 10/2019 < 5%
PETER KOLCHINSKY REVOCABLE TRUST Domestic Entity – PARTNER 10/2019 50-75%
RAJEEV M. SHAH FAMILY REVOCABLE TRUST Domestic Entity – PARTNER 10/2019 10-25%
KOLCHINSKY, PETER, (NMN) Individual PETER KOLCHINSKY REVOCABLE TRUST TRUSTEE 10/2019
SHAH, RAJEEV, MAHESH Individual RAJEEV M. SHAH FAMILY REVOCABLE TRUST TRUSTEE 10/2019
REED, SARAH, WATT BURGESS Individual – GENERAL COUNSEL 10/2019 < 5%
SAULNIER, MICHAEL Individual – CHIEF FINANCIAL OFFICER 01/2021 < 5%

No. Employees, Historic

2001000201920202021202220232024202570 on 7/12/201970 on 8/20/201970 on 11/1/201970 on 11/6/201973 on 3/30/202073 on 2/26/202199 on 3/31/202199 on 2/11/2022113 on 3/31/2022122 on 3/31/2023122 on 4/3/2023122 on 11/29/2023130 on 3/29/2024

RAUM, Historic

20B10B020192020202120222023202420253333470952 on 7/12/20193333470952 on 8/20/20193333470952 on 11/1/20193333470952 on 11/6/20194640923008 on 3/30/20204640923008 on 2/26/202111529102378 on 3/31/202112407552287 on 2/11/202210147001376 on 3/31/20229650336033 on 3/31/20239650336033 on 4/3/20239650336033 on 11/29/202311323065361 on 3/29/2024

No. Clients, Historic

105020192020202120222023202420254 on 7/12/20194 on 8/20/20194 on 11/1/20194 on 11/6/20194 on 3/30/20204 on 2/26/20216 on 3/31/20218 on 2/11/20228 on 3/31/20228 on 3/31/20238 on 4/3/20238 on 11/29/202310 on 3/29/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
4D MOLECULAR THERAPEUTICS IN SH 107M 5M –
89BIO INC SH 114M 14M –
ACRIVON THERAPEUTICS INC SH 48M 8M –
ACUMEN PHARMACEUTICALS INC SH 36M 15M –
ADICET BIO INC SH 9M 8M –
AEROVATE THERAPEUTICS INC SH 15M 9M –
AN2 THERAPEUTICS INC SH 12M 6M –
APOGEE THERAPEUTICS INC SH 77M 2M –
ARS PHARMACEUTICALS INC SH 92M 11M –
ARVINAS INC SH 11M 421K –
ASCENDIS PHARMA A/S - ADR SH 1B 10M –
ASTRIA THERAPEUTICS INC SH 46M 5M –
AVIDITY BIOSCIENCES INC SH 221M 5M –
AXSOME THERAPEUTICS INC SH 81M 1M –
BICYCLE THERAPEUTICS PLC-ADR SH 46M 2M –
BIOGEN INC SH 228M 982K –
BOUNDLESS BIO INC SH 8M 2M –
C4 THERAPEUTICS INC SH 23M 5M –
CHIMERIX INC SH 8M 9M –
CYBIN INC SH 12M 44M –
DAY ONE BIOPHARMACEUTICALS I SH 108M 8M –
DYNE THERAPEUTICS INC SH 213M 6M –
EDGEWISE THERAPEUTICS INC SH 160M 9M –
ELIEM THERAPEUTICS INC SH 206M 29M –
ELIEM THERAPEUTICS INC SH 18M 2M –
ENLIVEN THERAPEUTICS INC SH 50M 2M –
EVOLENT HEALTH INC - A SH 163M 9M –
FULCRUM THERAPEUTICS INC SH 72M 12M –
GERON CORP SH 196M 46M –
GH RESEARCH PLC SH 77M 7M –
IMMATICS NV SH 20M 2M –
ITEOS THERAPEUTICS INC SH 52M 4M –
JANUX THERAPEUTICS INC SH 384M 9M –
LARIMAR THERAPEUTICS INC SH 44M 6M –
LEGEND BIOTECH CORP-ADR SH 332M 8M –
LONGBOARD PHARMACEUTICALS IN SH 89M 3M –
MACROGENICS INC SH 9M 2M –
METAGENOMI INC SH 6M 1M –
MINERALYS THERAPEUTICS INC SH 57M 5M –
NEWAMSTERDAM PHARMA CO NV SH 155M 8M –
NEWAMSTERDAM PHARMA CO NV-27 SH 3M 333K –
NKARTA INC SH 64M 11M –
PEPGEN INC SH 171M 11M –
PLIANT THERAPEUTICS INC SH 14M 1M –
PRAXIS PRECISION MEDICINES I SH 51M 1M –
RHYTHM PHARMACEUTICALS INC SH 250M 6M –
RXSIGHT INC SH 222M 4M –
SERA PROGNOSTICS INC-A SH 18M 3M –
SOLID BIOSCIENCES INC SH 25M 4M –
STRUCTURE THERAPEUTICS INC SH 74M 2M –
TAYSHA GENE THERAPIES INC SH 24M 11M –
TENAYA THERAPEUTICS INC SH 24M 8M –
THIRD HARMONIC BIO INC SH 26M 2M –
TYRA BIOSCIENCES INC SH 167M 10M –
UNICYCIVE THERAPEUTICS INC SH 1M 3M –
UROGEN PHARMA LTD SH 52M 3M –
VAXCYTE INC SH 619M 8M –
VERONA PHARMA PLC - ADR SH 110M 8M –
VOR BIOPHARMA INC SH 23M 23M –
WAVE LIFE SCIENCES LTD SH 91M 18M –
WEREWOLF THERAPEUTICS INC SH 15M 6M –
LEXEO THERAPEUTICS INC SH 11M 673K –
ALTO NEUROSCIENCE INC SH 22M 2M –
REGULUS THERAPEUTICS INC SH 11M 6M –
CG ONCOLOGY INC SH 44M 1M –
ZURA BIO LTD SH 11M 3M –
ARCELLX INC SH 89M 2M –
DIANTHUS THERAPEUTICS INC SH 60M 2M –
INSMED INC SH 13M 200K –
NURIX THERAPEUTICS INC SH 14M 650K –
NUVALENT INC-A SH 9M 120K –
PROTARA THERAPEUTIC INC SH 4M 2M –
RECURSION PHARMACEUTICALS-A SH 115M 15M –
SCILEX HOLDING CO SH 504K 261K –
SURROZEN INC SH 3M 283K –
TOURMALINE BIO INC SH 33M 3M –
PERCEPTIVE CAPITAL SOLUTIONS SH 8M 750K –
LENZ THERAPEUTICS INC SH 72M 4M –
CERVOMED INC SH 14M 817K –